Glasgow-based company has played a leading role in bringing the world ’ s first robotic aortic valve replacement through a tiny incision in the neck significantly closer to reality . CardioPrecision – a specialist in less invasive treatment of structural heart disease – recently demonstrated a proof-of-concept AVATAR ( Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robotassistance ) procedure in Chicago .

The procedure was successfully performed on a series of human cadavers , representing an important milestone in progressing towards clinical cases while also continuing to grow CardioPrecision ’ s Stateside presence . The company – originally spun out of the NHS through InnoScot Health – utilised its CoreVista Robot Enabling Platform as well as the PercevaL Plus sutureless aortic heart valve from UK-based Corcym , a global medical device company focused on the structural heart area .

CardioPrecision ’ s Chief Medical Officer and Consultant Cardiothoracic Surgeon , Fraser Sutherland , worked closely with Rocco Bilancia , consultant thoracic surgeon at Scotland ’ s Golden Jubilee University National Hospital , to introduce AVATAR to leading US robotic surgeons , Professor Husam Balkhy from the University of Chicago Medicine and Professor Danny Ramzy at Memorial Hermann of University of Texas Houston .

A Scottish Government investment of around £ 20 million in 10 surgical robots was announced in 2021 and further investment in robotics is anticipated nationwide .

Prof Rowan Parks , President of Royal College of Surgeons of Edinburgh and previous Chair of the RCSEd Robotic Taskforce , said : “ There is clearly vast potential here and it is exciting to see a Glasgow company helping to lead the way while putting Scotland firmly on the map for this pioneering approach .

“ Robotic cardiac surgery is much less invasive than open-heart surgery . Fundamentally , it removes the necessity of the surgeon having to cut through the breastbone to open the chest , in turn removing many access-related complications . This could well be just the start of more complex surgeries with quick advances being made , benefitting both patient and surgeon .”

The Zetaris Healthcare Studio enables improvements in triage to enable healthcare professionals to make faster decisions . By using data from thousands of previous cases , they can determine the right treatment path faster than ever before to accelerate triage and support better resource allocation . The Zetaris Healthcare Studio is a powerful tool for faster and more accurate disease detection .

Zetaris caused a buzz with the with the recent launch of its Healthcare Data for Artificial Intelligence ( AI ) Studio at HIMSS Jakarta , an innovation designed to elevate patient and clinician experiences through an AI ready workspace for the delivery of advanced clinical and research outcomes .

Clinicians can now leverage data and AI to optimise their human-centric processes to significantly improve medical outcomes . For instance , emergency departments can use data with AI and Machine Learning ( ML ) to prioritise and elevate care . Lifesciences can accelerate the development of new solutions that can alleviate human suffering from chronic disease to reduce the pressure on hospitals and the aged care system . Labs can work alone or collaborate to gain faster insights from real-time integrated data .

Vinay Samuel , CEO and Founder , Zetaris , said : “ Get ready to revolutionise the way you leverage data in healthcare . Our cutting-edge AI studio empowers clinicians and healthcare providers in Australia and globally to unlock the full potential of data , drive smarter decisions and deliver superior patient outcomes .”

www . intelligenthealth . tech 7